百龙创园：拟1000万元设立南京全资子公司

Core Viewpoint - The company, Bailong Chuangyuan (605016.SH), has announced the establishment of a wholly-owned subsidiary, Bailong Chuangyuan (Nanjing) Biotechnology Co., Ltd., with an investment of 10 million RMB to enhance its international market presence and sales team [1] Group 1 - The investment aims to strengthen the overseas sales team and actively explore international markets [1] - The company will leverage Nanjing's geographical advantages to expand overseas customer development and technical exchanges [1] - This initiative is expected to increase the company's export revenue and enhance its overall profitability and overseas customer service capabilities [1]